Search alternatives:
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Study selection criteria.
Published 2025“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”
-
7
PICOS criteria for the SLR.
Published 2025“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”
-
8
PRISMA flow chart.
Published 2025“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”
-
9
-
10
-
11
-
12
-
13
Mean conidial viability of <i>Beauveria</i> and <i>Metarhizium</i> isolates.
Published 2024Subjects: -
14
-
15
-
16
-
17
-
18
-
19
-
20